Esperion Therapeutics ESPR Convertible Preferred Stock Outstanding Shares
Convertible Preferred Stock Outstanding Shares at other companies
Other financials
Where this comes from
Reported directly by Esperion Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesOutstanding.
The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Esperion Therapeutics's convertible preferred stock outstanding shares.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Esperion Therapeutics's convertible preferred stock outstanding shares?
- Esperion Therapeutics (ESPR) reported convertible preferred stock outstanding shares of 0 in Q1 2026.
- What does convertible preferred stock outstanding shares mean?
- This represents the total number of preferred shares that carry the right to be converted into common stock. It is a key metric for calculating fully diluted share counts and understanding the potential impact on existing shareholder ownership. Investors monitor this to assess the potential for future equity dilution and the influence of preferred shareholders on corporate governance.